日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes

度拉糖肽、索玛鲁肽和替拉帕肽在2型糖尿病成人患者中的胃肠道安全性比较

期刊:Annals of Internal Medicine
影响因子:15.2
doi:10.7326/ANNALS-25-01724
Crisafulli, Salvatore; Alkabbani, Wajd; Paik, Julie M; Bykov, Katsiaryna; Tavakkoli, Ali; Glynn, Robert J; Htoo, Phyo T; Yu, Elaine W; Trifirò, Gianluca; Wexler, Deborah J; Patorno, Elisabetta
糖尿病
代谢
发表日期：2026
文献求助 收藏

Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes

恩格列净与2型糖尿病患者视网膜病变风险

期刊:Jama Ophthalmology
影响因子:9.2
doi:10.1001/jamaophthalmol.2024.5219
Tesfaye, Helen; Paik, Julie M; Roh, Miin; Htoo, Phyo T; Zakoul, Heidi; Schmedt, Niklas; Koeneman, Lisette; Wexler, Deborah J; Patorno, Elisabetta
糖尿病
视网膜病变
神经科学
代谢
发表日期：2025
文献求助 收藏

Machine learning for predicting cardiovascular events in older adults with type 2 diabetes using Medicare claims and electronic health records

利用医疗保险索赔数据和电子健康记录，通过机器学习预测老年 2 型糖尿病患者的心血管事件

期刊:Journal of Clinical Epidemiology
影响因子:5.2
doi:10.1016/j.jclinepi.2025.112001
Htoo, Phyo T; Paik, Julie M; Everett, Brendan M; Glynn, Robert J; Bykov, Katsiaryna; Hahn, Georg; Liu, Jun; Wexler, Deborah J; Patorno, Elisabetta
糖尿病
代谢
发表日期：2025
文献求助 收藏

A systematic approach to evaluating instrumental variable assumptions: applied example of glucose-lowering medications and risk for hospitalized heart failure in older adults

系统性评估工具变量假设的方法：以降血糖药物与老年人住院心力衰竭风险为例

期刊:American Journal of Epidemiology
影响因子:4.8
doi:10.1093/aje/kwae329
Htoo, Phyo T; Edwards, Jessie K; Gokhale, Mugdha; Pate, Virginia; Buse, John B; Jonsson-Funk, Michele; Stürmer, Til
心力衰竭
心血管
发表日期：2025
文献求助 收藏

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

恩格列净与胰高血糖素样肽-1受体激动剂的心肾疗效比较：EMPRISE研究的最终年结果

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-024-02150-0
Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Schmedt, Niklas; Koeneman, Lisette; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta
信号转导
发表日期：2024
文献求助 收藏

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

更正：恩格列净与胰高血糖素样肽-1受体激动剂的心肾疗效比较：EMPRISE研究的最终年结果

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-024-02190-6
Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Schmedt, Niklas; Koeneman, Lisette; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta
信号转导
发表日期：2024
文献求助 收藏

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia

澳大利亚墨尔本注射吸毒者开始接受丙型肝炎治疗的时间

期刊:Epidemiology and Infection
影响因子:2.2
doi:10.1017/S0950268823000675
Aung, Phyo T Z; Spelman, Tim; Wilkinson, Anna L; Dietze, Paul M; Stoové, Mark A; Hellard, Margaret E
肝炎
发表日期：2023
文献求助 收藏

Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk

根据已知低血糖风险指标对老年 2 型糖尿病患者使用新型二线降糖药物发生严重低血糖的风险进行分层分析

期刊:
影响因子:
doi:10.1093/gerona/glad075
Htoo, Phyo T; Paik, Julie M; Alt, Ethan; Kim, Dae Hyun; Wexler, Deborah J; Kim, Seoyoung C; Patorno, Elisabetta
糖尿病
代谢
发表日期：2023
文献求助 收藏

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics

恩格列净与利拉鲁肽或西格列汀在具有不同患者特征的老年患者中的疗效比较

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2022.37606
Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Kim, Seoyoung C; Najafzadeh, Mehdi; Koeneman, Lisette; Farsani, Soulmaz Fazeli; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta
发表日期：2022
文献求助 收藏

Cardiovascular Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure

在常规临床护理中，对于有或无动脉粥样硬化性心血管疾病或心力衰竭病史的老年患者，钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的心血管疗效

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.121.022376
Htoo, Phyo T; Buse, John; Cavender, Matthew; Wang, Tiansheng; Pate, Virginia; Edwards, Jess; Stürmer, Til
信号转导
心血管疾病
心血管
心力衰竭
动脉粥样硬化
发表日期：2022
文献求助 收藏